The influence of adjuvant radiotherapy on patterns of failure and survivals in uterine carcinosarcoma (Q36196011)

12 August 2017

The influence of adjuvant radiotherapy on patterns of failure and survivals in uterine carcinosarcoma (English)

1 reference

12 August 2017

Hae Jin Park

1

1 reference

12 August 2017

Hak Jae Kim

2

1 reference

12 August 2017

Hong-Gyun Wu

3

1 reference

12 August 2017

Hans Kim

4

1 reference

12 August 2017

Sung Whan Ha

5

1 reference

12 August 2017

Soon-Beom Kang

6

1 reference

12 August 2017

Yong-Sang Song

7

1 reference

12 August 2017

Noh-Hyun Park

8

1 reference

12 August 2017

Jae-Won Kim

9

1 reference

12 August 2017

28 December 2011

1 reference

Radiation oncology journal

12 August 2017

1 reference

12 August 2017

29

1 reference

12 August 2017

4

1 reference

12 August 2017

228-235

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

12 August 2017

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Current management of uterine sarcomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed müllerian tumors of the uterus

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

The role of adjuvant radiation in uterine sarcomas

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

Multimodality therapy for patients with clinical Stage I and II malignant mixed Müllerian tumors of the uterus

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

Uterine carcinosarcomas: incidence and trends in management and survival

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3429907

A comparison between different postoperative treatment modalities of uterine carcinosarcoma

22 September 2018

1 reference

12 December 2020

Revised FIGO staging for carcinoma of the cervix

1 reference

12 December 2020

Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases

1 reference

12 December 2020

Carcinosarcoma of the Uterus: A Clinicopathological Multicenter CTF Study

1 reference

12 December 2020

Malignant mixed müllerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival

1 reference

12 December 2020

10.3857/ROJ.2011.29.4.228

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

1 reference